Monitoring and integrated care coordination of patients with alpha-mannosidosis: A global Delphi consensus study
Language English Country United States Media print-electronic
Document type Journal Article
PubMed
39024860
DOI
10.1016/j.ymgme.2024.108519
PII: S1096-7192(24)00403-7
Knihovny.cz E-resources
- Keywords
- Alpha-mannosidosis, Best practice, Delphi, Follow-up, International, Monitoring,
- MeSH
- alpha-Mannosidosis * therapy diagnosis MeSH
- Delphi Technique * MeSH
- Delivery of Health Care, Integrated standards MeSH
- Consensus * MeSH
- Humans MeSH
- Surveys and Questionnaires MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
INTRODUCTION: Current literature lacks consensus on initial assessments and routine follow-up care of patients with alpha-mannosidosis (AM). A Delphi panel was conducted to generate and validate recommendations on best practices for initial assessment, routine follow-up care, and integrated care coordination of patients with AM. METHODS: A modified Delphi method involving 3 rounds of online surveys was used. An independent administrator and 2 nonvoting physician co-chairs managed survey development, anonymous data collection, and analysis. A multidisciplinary panel comprising 20 physicians from 12 countries responded to 57 open-ended questions in the first survey. Round 2 consisted of 11 ranking questions and 44 voting statements. In round 3, panelists voted to validate 60 consensus statements. The panel response rate was ≥95% in all 3 rounds. Panelists used 5-point Likert scales to indicate importance (score of ≥3) or agreement (score of ≥4). Consensus was defined a priori as ≥75% agreement with ≥75% of panelists voting. RESULTS: Consensus was reached on 60 statements, encompassing 3 key areas: initial assessments, routine follow-up care, and treatment-related follow-up. The panel agreed on the type and frequency of assessments related to genetic testing, baseline evaluations, quality of life, biochemical measures, affected body systems, treatment received, and integrated care coordination in patients with AM. Forty-nine statements reached 90% to 100% consensus, 8 statements reached 80% to 85% consensus, and 1 statement reached 75% consensus. Two statements each reached consensus on 15 baseline assessments to be conducted at the initial follow-up visit after diagnosis in pediatric and adult patients. CONCLUSION: This is the first Delphi study providing internationally applicable, best-practice recommendations for monitoring patients with AM that may improve their care and well-being.
Baylor College of Medicine and Texas Children's Hospital Houston TX USA
Boston Children's Hospital Harvard Medical School Boston MA USA
Division of Genetics Centro de Investigación Biomédica de Occidente Guadalajara Mexico
Federal University of Rio Grande do Sul Porto Alegre Brazil
Greenwood Genetic Center Greenwood SC USA
Hospital Universitario Ramón Y Cajal Instituto Ramón y Cajal de Investigación Sanitaria Madrid Spain
Nicklaus Children's Hospital Miami FL USA
Northwestern University and Ann and Robert H Lurie Children's Hospital of Chicago Chicago IL USA
Reference Centre for Inherited Metabolic Diseases Lyon France
Regional Coordinating Center for Rare Diseases University Hospital Udine Italy
Reina Sofía University Hospital Maimonides Biomedical Research Institute of Cordoba Córdoba Spain
Sydney Children's Hospital Network Sydney Australia
The University of Texas Southwestern Medical Center Dallas TX USA
Villa Metabolica University Medical Center Mainz Mainz Germany
References provided by Crossref.org